中科微点-全球专利检索

  1. Login
  2. Sign Up
Invention Grant
US09592208B2 Formulations comprising 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol 有权
包含2-氨基-2- [2-（4-辛基苯基）乙基]丙烷-1,3-二醇的制剂

  • Patent Title: Formulations comprising 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol
  • Patent Title (中): 包含2-氨基-2- [2-（4-辛基苯基）乙基]丙烷-1,3-二醇的制剂
  • Application No.: US14009241
    Application Date: 2012-03-30
  • Publication No.: US09592208B2
    Publication Date: 2017-03-14
  • Inventor: Supriya Rane
  • Applicant: Supriya Rane
  • Applicant Address: CH Basel
  • Assignee: Novartis AG
  • Current Assignee: Novartis AG
  • Current Assignee Address: CH Basel
  • Agent Andrew Holmes
  • International Application: PCT/US2012/031340 WO 20120330
  • International Announcement: WO2012/135561 WO 20121004
  • Main IPC: A61K31/137
  • IPC: A61K31/137 ;  A61K47/40 ;  A61K9/48 ;  A61K9/20 ;  A61K31/661 ;  A61K9/16
Formulations comprising 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol
Abstract:
A solid pharmaceutical composition suitable for oral administration, comprising: (a) a S1P receptor modulator; (b) a filler, and (c) a cyclodextrin.
Abstract(Chinese):

一种适用于口服给药的固体药物组合物，包括：（a）S1P受体调节剂; （b）填料，和（c）环糊精。

Public/Granted literature
Information query
Espacenet
Patent Agency Ranking
0/0